ATRICURE INC's ticker is ATRC and the CUSIP is 04963C209. A total of 228 filers reported holding ATRICURE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $516,095 | -15.2% | 11,783 | -4.4% | 0.01% | -11.1% |
Q2 2023 | $608,510 | +18.5% | 12,328 | -0.5% | 0.01% | +12.5% |
Q1 2023 | $513,400 | -13.7% | 12,386 | -7.6% | 0.01% | -20.0% |
Q4 2022 | $594,736 | +12.0% | 13,401 | -1.3% | 0.01% | 0.0% |
Q3 2022 | $531,000 | -4.3% | 13,577 | -0.0% | 0.01% | -9.1% |
Q2 2022 | $555,000 | -37.8% | 13,578 | 0.0% | 0.01% | -26.7% |
Q1 2022 | $892,000 | -7.4% | 13,578 | -1.9% | 0.02% | -6.2% |
Q4 2021 | $963,000 | -1.9% | 13,845 | -1.9% | 0.02% | -15.8% |
Q3 2021 | $982,000 | -13.9% | 14,117 | -1.9% | 0.02% | -17.4% |
Q2 2021 | $1,141,000 | +25.2% | 14,387 | +3.5% | 0.02% | +15.0% |
Q1 2021 | $911,000 | +16.9% | 13,899 | -0.6% | 0.02% | +5.3% |
Q4 2020 | $779,000 | +36.4% | 13,989 | -2.3% | 0.02% | +11.8% |
Q3 2020 | $571,000 | +82.4% | 14,322 | +105.5% | 0.02% | +70.0% |
Q2 2020 | $313,000 | +23.2% | 6,969 | -8.0% | 0.01% | 0.0% |
Q1 2020 | $254,000 | -15.9% | 7,571 | -18.6% | 0.01% | 0.0% |
Q4 2019 | $302,000 | +9.0% | 9,300 | -16.4% | 0.01% | -16.7% |
Q3 2019 | $277,000 | -18.8% | 11,125 | -2.8% | 0.01% | -20.0% |
Q2 2019 | $341,000 | – | 11,443 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 350,000 | $13,965,000 | 4.30% |
SECTORAL ASSET MANAGEMENT INC | 708,717 | $28,278,000 | 2.43% |
First Light Asset Management, LLC | 561,018 | $22,385,000 | 2.29% |
DAFNA Capital Management LLC | 133,229 | $5,316,000 | 1.73% |
PERKINS CAPITAL MANAGEMENT INC | 44,350 | $1,770,000 | 1.63% |
PURA VIDA INVESTMENTS, LLC | 645,003 | $25,736,000 | 1.33% |
Acuitas Investments, LLC | 46,353 | $1,849,000 | 1.30% |
EMERALD MUTUAL FUND ADVISERS TRUST | 477,064 | $19,035,000 | 0.84% |
EMERALD ADVISERS, LLC | 500,848 | $19,984,000 | 0.82% |
Orbimed Advisors | 1,228,189 | $49,005,000 | 0.62% |